Post-stent DAPT, a new PPI and self-medicated ibuprofen: ranking interacting problems in community pharmacy
A 63-year-old man attends your community pharmacy for a medication review three months after percutaneous coronary intervention with a drug-eluting stent. His cardiologist's list is: aspirin 75 mg daily, clopidogrel 75 mg daily, atorvastatin 80 mg at night, bisoprolol 5 mg, ramipril 5 mg, metformin 1 g twice daily. Recent eGFR is 42 mL/min/1.73 m²; Hb 11.8 g/dL. He has just seen a gastroenterologist for two months of epigastric burning, who started omeprazole 20 mg daily without mentioning his cardiac history. For the past three weeks he has also been taking ibuprofen 400 mg three times daily, bought over the counter, for knee osteoarthritis that has worsened; he says it is "the only thing that works" and he is reluctant to stop. Today he reports that the burning is better but he feels tired and his knees are still painful. He asks whether the omeprazole and the ibuprofen can simply be added to his regular prescription list.
1. Identify the drug-related problems and rank them by urgency, explaining the mechanism and probable consequence of each.
Read the worked answer
1 (most urgent) - Aspirin plus regular ibuprofen: gastrointestinal bleeding. Dual antiplatelet therapy plus an NSAID multiplies ulcer and bleeding risk several-fold, and the falling Hb (11.8 g/dL) with new fatigue and epigastric symptoms is exactly the presentation of an eroded, bleeding mucosa. Ibuprofen also competitively blocks aspirin's irreversible COX-1 acetylation at the platelet site if taken before aspirin, blunting cardioprotection.
2 - Ibuprofen in CKD stage 3b (eGFR 42). Prostaglandin-dependent afferent arteriolar dilation is lost, risking acute kidney injury on top of chronic disease. Combined with ramipril (and any volume depletion) this is the classic "triple whammy" territory; NSAIDs are generally to be avoided below an eGFR of about 60.
3 - Omeprazole and clopidogrel. Omeprazole is a strong CYP2C19 inhibitor and clopidogrel is a prodrug requiring CYP2C19 activation; the product label warns against concomitant use. The clinical magnitude is debated (the COGENT randomised trial found no excess cardiovascular events with omeprazole), but the fix is cheap and the patient is three months post-stent - do not gamble.
4 - Under-treated indication and an unrecognised prescribing cascade. The PPI is appropriate in a patient on DAPT; the problem is that it was started without anyone addressing the NSAID, and the knee pain remains uncontrolled.
5 - Secondary. Metformin at 2 g/day with eGFR 42 warrants dose review (many protocols cap at 1 g/day below eGFR 45); anaemia needs a cause, not just a number.
2. Propose a concrete revised plan covering PPI choice, analgesia and monitoring, with the reasoning behind each choice.
Read the worked answer
Stop the ibuprofen today. Explain the bleeding and kidney risk in plain terms and offer substitutes rather than a bare prohibition - this is what determines adherence.
Analgesia for knee osteoarthritis in CKD with coronary disease:
- Topical diclofenac 1% gel, 4 g to the knee four times daily: systemic exposure is roughly 6% of oral, so it is a reasonable compromise with the patient's agreement and monitoring.
- Paracetamol up to 3 g/day as background analgesia.
- Physiotherapy, weight management and a walking aid - slow to work but the only disease-modifying levers here.
- Intra-articular corticosteroid if the knee is inflamed and infection has been excluded.
- Avoid codeine (variable CYP2D6 activation, metabolite accumulation in renal impairment) and use tramadol only with dose reduction and awareness of serotonergic and hypoglycaemia effects.
PPI: switch omeprazole to pantoprazole 40 mg daily (or rabeprazole 20 mg) - minimal CYP2C19 inhibition, both in the health basket, no cost barrier. Do not rely on separating administration times; that does not reliably solve an enzyme-induction/inhibition problem of this kind.
Monitoring: full blood count and renal function in 1–2 weeks; ask specifically about black stools, dyspnoea and dizziness; test for H. pylori (stool antigen or urea breath test) since he has dyspepsia on antiplatelet therapy, and treat if positive; review metformin dose with his physician; record the OTC NSAID in the pharmacy's medication record and counsel him to check before any future OTC purchase.
3. He asks whether he can just stop the clopidogrel instead, since "the stent is old". How do you answer, and what would you communicate to the prescribers?
Read the worked answer
Answer to the patient. No - do not stop anything on your own. At three months after a drug-eluting stent he is still inside the period of highest stent-thrombosis risk; stopping clopidogrel early can cause an acute myocardial infarction, which is far more dangerous than the interaction we are fixing. The interaction with omeprazole is solved by changing the PPI, not the antiplatelet.
Clinical reasoning behind the answer. Standard DAPT duration after a second-generation drug-eluting stent is 6–12 months, individualised for bleeding versus ischaemic risk. He has a high bleeding-risk profile (anaemia, NSAID use, upcoming GI workup), so the cardiologist may legitimately shorten DAPT - but that is a cardiology decision with the full angiographic and clinical picture, not a pharmacy counter decision.
Do not switch to prasugrel or ticagrelor reflexively. Prasugrel is contraindicated with a history of stroke and carries higher bleeding risk; ticagrelor adds dyspnoea and cost, and neither is needed to solve a PPI interaction. Genotype-guided switching (CYP2C19 poor metaboliser) is a separate question and not supported by this scenario alone.
Communication. Send the cardiologist a short structured note: the OTC NSAID, the Hb and eGFR, the PPI change, and a request to confirm intended DAPT duration and to advise on gastrointestinal investigation. Send the gastroenterologist the antiplatelet history so the PPI choice and any endoscopy planning account for it. Give the patient a written list of what changed and what did not, and tell him to bring it to both appointments.